Cofactors and metabolites as potential stabilizers of mitochondrial acyl-CoA dehydrogenases

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 12, 2011, Pages 1658-1663

  Lucas, Tânia G ^a   Henriques, Bárbara J ^a   Rodrigues, João V ^a   Bross, Peter ^b   Gregersen, Niels ^b   Gomes, Cláudio M ^a  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acyl CoA dehydrogenase; Chemical chaperone; Differential scanning fluorimetry; Fatty acid oxidation; Substrate; Thermofluor

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; FLAVINE ADENINE NUCLEOTIDE; GLUTARYL COENZYME A DEHYDROGENASE; LYSINE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; RIBOFLAVIN; TRYPTOPHAN;

ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME STABILITY; IN VITRO STUDY; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN METABOLISM; THERMOSTABILITY;

ACYL COENZYME A; ACYL-COA DEHYDROGENASE; BUTYRYL-COA DEHYDROGENASE; CALORIMETRY, DIFFERENTIAL SCANNING; CATALYTIC DOMAIN; COENZYMES; ENZYME ASSAYS; ENZYME STABILITY; FLAVIN-ADENINE DINUCLEOTIDE; GLUTARYL-COA DEHYDROGENASE; HUMANS; MITOCHONDRIAL PROTEINS; PROTEIN BINDING; PROTEIN UNFOLDING; RIBOFLAVIN; TRANSITION TEMPERATURE;

EID: 80054078305     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.09.009     Document Type: Article

References (35)

1. Roberts D.L., Frerman F.E., Kim J.J. Three-dimensional structure of human electron transfer flavoprotein to 2.1-A resolution. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:14355-14360.
2. Zhang J., Frerman F.E., Kim J.J. Structure of electron transfer flavoprotein-ubiquinone oxidoreductase and electron transfer to the mitochondrial ubiquinone pool. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16212-16217.
3. Ghisla S., Thorpe C. Acyl-CoA dehydrogenases. A mechanistic overview. Eur. J. Biochem. 2004, 271:494-508.
4. Kim J.J., Miura R. Acyl-CoA dehydrogenases and acyl-CoA oxidases. Structural basis for mechanistic similarities and differences. Eur. J. Biochem. 2004, 271:483-493.
5. Hoffmann G.F., von Kries R., Klose D., Lindner M., Schulze A., Muntau A.C., Roschinger W., Liebl B., Mayatepek E., Roscher A.A. Frequencies of inherited organic acidurias and disorders of mitochondrial fatty acid transport and oxidation in Germany. Eur. J. Pediatr. 2004, 163:76-80.
6. Maier E.M., Liebl B., Roschinger W., Nennstiel-Ratzel U., Fingerhut R., Olgemoller B., Busch U., Krone N., Kries R.v, Roscher A.A. Population spectrum of ACADM genotypes correlated to biochemical phenotypes in newborn screening for medium-chain acyl-CoA dehydrogenase deficiency. Hum. Mutat. 2005, 25:443-452.
7. Andresen B.S., Dobrowolski S.F., O'Reilly L., Muenzer J., McCandless S.E., Frazier D.M., Udvari S., Bross P., Knudsen I., Banas R., Chace D.H., Engel P., Naylor E.W., Gregersen N. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am. J. Hum. Genet. 2001, 68:1408-1418.
8. Kolker S., Christensen E., Leonard J.V., Greenberg C.R., Boneh A., Burlina A.B., Burlina A.P., Dixon M., Duran M., Garcia Cazorla A., Goodman S.I., Koeller D.M., Kyllerman M., Muhlhausen C., Muller E., Okun J.G., Wilcken B., Hoffmann G.F., Burgard P. Diagnosis and management of glutaric aciduria type I - revised recommendations. J. Inherit. Metab. Dis. 2011, 34:677-694.
9. Rector R.S., Ibdah J.A. Fatty acid oxidation disorders: maternal health and neonatal outcomes. Semin. Fetal Neonatal Med. 2010, 15:122-128.
10. Keyser B., Muhlhausen C., Dickmanns A., Christensen E., Muschol N., Ullrich K., Braulke T. Disease-causing missense mutations affect enzymatic activity, stability and oligomerization of glutaryl-CoA dehydrogenase (GCDH). Hum. Mol. Genet. 2008, 17:3854-3863.
11. Gregersen N., Andresen B.S., Pedersen C.B., Olsen R.K., Corydon T.J., Bross P. Mitochondrial fatty acid oxidation defects-remaining challenges. J. Inherit. Metab. Dis. 2008, 31:643-657.
12. Gregersen N., Bross P., Vang S., Christensen J.H. Protein misfolding and human disease. Annu. Rev. Genomics Hum. Genet. 2006, 7:103-124.
13. Saijo T., Tanaka K. Isoalloxazine ring of FAD is required for the formation of the core in the Hsp60-assisted folding of medium chain acyl-CoA dehydrogenase subunit into the assembly competent conformation in mitochondria. J. Biol. Chem. 1995, 270:1899-1907.
14. Henriques B.J., Rodrigues J.V., Olsen R.K., Bross P., Gomes C.M. Role of flavinylation in a mild variant of multiple acyl-CoA dehydrogenation deficiency: a molecular rationale for the effects of riboflavin supplementation. J. Biol. Chem. 2009, 284:4222-4229.
15. Leandro P., Gomes C.M. Protein misfolding in conformational disorders: rescue of folding defects and chemical chaperoning. Mini Rev. Med. Chem. 2008, 8:901-911.
16. Henriques B.J., Olsen R.K., Bross P., Gomes C.M. Emerging roles for riboflavin in functional rescue of mitochondrial beta-oxidation flavoenzymes. Curr. Med. Chem. 2010, 17:3842-3854.
17. Duran M., Cleutjens C.B.J.M., Ketting D., Dorland L., Deklerk J.B.C., Vansprang F.J., Berger R. Diagnosis of medium-chain acyl-Coa dehydrogenase-deficiency in lymphocytes and liver by a gas-chromatographic method - the effect of oral riboflavin supplementation. Pediatr. Res. 1992, 31:39-42.
18. van Maldegem B.T., Duran M., Wanders R.J.A., Waterham H.R., Wijburg F.A. Flavin adenine dinucleotide status and the effects of high-dose riboflavin treatment in short-chain acyl-CoA dehydrogenase deficiency. Pediatr. Res. 2010, 67:304-308.
19. Brandt N.J., Gregersen N., Christensen E., Gron I.H., Rasmussen K. Treatment of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria). Experience with diet, riboflavin, and GABA analogue. J. Pediatr. 1979, 94:669-673.
20. Bross P., Jespersen C., Jensen T.G., Andresen B.S., Kristensen M.J., Winter V., Nandy A., Krautle F., Ghisla S., Bolundi L., Kim J.J., Gregersen N. Effects of two mutations detected in medium chain acyl-CoA dehydrogenase (MCAD)-deficient patients on folding, oligomer assembly, and stability of MCAD enzyme. J. Biol. Chem. 1995, 270:10284-10290.
21. Nguyen T.V., Riggs C., Babovic-Vuksanovic D., Kim Y.S., Carpenter J.F., Burghardt T.P., Gregersen N., Vockley J. Purification and characterization of two polymorphic variants of short chain acyl-CoA dehydrogenase reveal reduction of catalytic activity and stability of the Gly185Ser enzyme. Biochemistry 2002, 41:11126-11133.
22. Thorpe C., Matthews R.G., Williams C.H. Acyl-coenzyme A dehydrogenase from pig kidney. Purification and properties, Biochemistry 1979, 18:331-337.
23. Niesen F.H., Berglund H., Vedadi M. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat. Protoc. 2007, 2:2212-2221.
24. Rodrigues J.V., Prosinecki V., Marrucho I., Rebelo L.P., Gomes C.M. Protein stability in an ionic liquid milieu: on the use of differential scanning fluorimetry. Phys. Chem. Chem. Phys. 2011, 13:13614-13616.
25. Bennett B.D., Kimball E.H., Gao M., Osterhout R., Van Dien S.J., Rabinowitz J.D. Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli. Nat. Chem. Biol. 2009, 5:593-599.
26. Gianazza E., Vergani L., Wait R., Brizio C., Brambilla D., Begum S., Giancaspero T.A., Conserva F., Eberini I., Bufano D., Angelini C., Pegoraro E., Tramontano A., Barile M. Coordinated and reversible reduction of enzymes involved in terminal oxidative metabolism in skeletal muscle mitochondria from a riboflavin-responsive, multiple acyl-CoA dehydrogenase deficiency patient. Electrophoresis 2006, 27:1182-1198.
27. Correia A.R., Wang T., Craig E.A., Gomes C.M. Iron-binding activity in yeast frataxin entails a trade off with stability in the alpha1/beta1 acidic ridge region. Biochem. J. 2010, 426:197-203.
28. Gregersen N., Winter V.S., Corydon M.J., Corydon T.J., Rinaldo P., Ribes A., Martinez G., Bennett M.J., Vianey-Saban C., Bhala A., Hale D.E., Lehnert W., Kmoch S., Roig M., Riudor E., Eiberg H., Andresen B.S., Bross P., Bolund L.A., Kolvraa S. Identification of four new mutations in the short-chain acyl-CoA dehydrogenase (SCAD) gene in two patients: one of the variant alleles, 511C->T, is present at an unexpectedly high frequency in the general population, as was the case for 625G->A, together conferring susceptibility to ethylmalonic aciduria. Hum. Mol. Genet. 1998, 7:619-627.
29. Pedersen C.B., Zolkipli Z., Vang S., Palmfeldt J., Kjeldsen M., Stenbroen V., Schmidt S.P., Wanders R.J., Ruiter J.P., Wibrand F., Tein I., Gregersen N. Antioxidant dysfunction: potential risk for neurotoxicity in ethylmalonic aciduria. J. Inherit. Metab. Dis. 2010, 33:211-222.
30. Jethva R., Bennett M.J., Vockley J. Short-chain acyl-coenzyme A dehydrogenase deficiency. Mol. Genet. Metab. 2008, 95:195-200.
31. Zheng W., Padia J., Urban D.J., Jadhav A., Goker-Alpan O., Simeonov A., Goldin E., Auld D., LaMarca M.E., Inglese J., Austin C.P., Sidransky E. Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:13192-13197.
32. Yu Z., Sawkar A.R., Kelly J.W. Pharmacologic chaperoning as a strategy to treat Gaucher disease. FEBS J. 2007, 274:4944-4950.
33. Djouadi F., Aubey F., Schlemmer D., Ruiter J.P., Wanders R.J., Strauss A.W., Bastin J. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders. Hum. Mol. Genet. 2005, 14:2695-2703.
34. Bonnefont J.P., Bastin J., Behin A., Djouadi F. Bezafibrate for an inborn mitochondrial beta-oxidation defect. N. Engl. J. Med. 2009, 360:838-840.
35. Nagao M., Tanaka K. FAD-dependent regulation of transcription, translation, post-translational processing, and post-processing stability of various mitochondrial acyl-CoA dehydrogenases and of electron transfer flavoprotein and the site of holoenzyme formation. J. Biol. Chem. 1992, 267:17925-17932.